Phospho-alpha 1 Catenin (Ser655/Thr658) Antibody - #DF2984

(2)  
製品: Phospho-alpha 1 Catenin (Ser655/Thr658) Antibody
カタログ: DF2984
タンパク質の説明: Rabbit polyclonal antibody to Phospho-alpha 1 Catenin (Ser655/Thr658)
アプリケーション: WB
反応性: Human, Mouse
分子量: 100KD; 100kD(Calculated).
ユニプロット: P35221
RRID: AB_2840963

類似製品を見る>>

   サイズ 価格 在庫状況
 100ul $280 在庫あり
 200ul $350 在庫あり

リードタイム: 当日配達

For pricing and ordering contact:
お問い合わせ先
関連ダウンロード
MSDS
説明書
COA
プロトコル
WB Handbook
IHC Protocol
IF/ICC Protocol

製品説明

ソース:
Rabbit
アプリケーション:
WB 1:1000-3000
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

反応性:
Human,Mouse
クローナリティ:
Polyclonal
特異性:
Phospho-alpha 1 Catenin (Ser655/Thr658) Antibody detects endogenous levels of alpha 1 Catenin only when phosphorylated at Ser655/Thr658.
RRID:
AB_2840963
引用形式: Affinity Biosciences Cat# DF2984, RRID:AB_2840963.
コンジュゲート:
Unconjugated.
精製:
The antibody is from purified rabbit serum by affinity purification via sequential chromatography on phospho-peptide and non-phospho-peptide affinity columns.
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
別名:

折りたたみ／展開

Alpha E-catenin; Cadherin associated protein 102kDa; Cadherin associated protein; Cadherin-associated protein; CAP 102; CAP102; Catenin (cadherin associated protein) alpha 1 102kDa; Catenin (cadherin associated protein), alpha 1, 102kDa; Catenin alpha 1; Catenin alpha-1; CTNA1_HUMAN; CTNNA 1; Ctnna1; FLJ36832; FLJ52416; MDPT2; NY REN 13 antigen; OTTHUMP00000224141; OTTHUMP00000224147; Renal carcinoma antigen NY REN 13; Renal carcinoma antigen NY-REN-13;

免疫原

免疫原:
Uniprot:

P35221(CTNA1_HUMAN) >>Visit HPA database.

遺伝子(ID):
CTNNA1(1495)
発現特異性:
P35221 CTNA1_HUMAN:

Expressed ubiquitously in normal tissues.

タンパク質配列:
MTAVHAGNINFKWDPKSLEIRTLAVERLLEPLVTQVTTLVNTNSKGPSNKKRGRSKKAHVLAASVEQATENFLEKGDKIAKESQFLKEELVAAVEDVRKQGDLMKAAAGEFADDPCSSVKRGNMVRAARALLSAVTRLLILADMADVYKLLVQLKVVEDGILKLRNAGNEQDLGIQYKALKPEVDKLNIMAAKRQQELKDVGHRDQMAAARGILQKNVPILYTASQACLQHPDVAAYKANRDLIYKQLQQAVTGISNAAQATASDDASQHQGGGGGELAYALNNFDKQIIVDPLSFSEERFRPSLEERLESIISGAALMADSSCTRDDRRERIVAECNAVRQALQDLLSEYMGNAGRKERSDALNSAIDKMTKKTRDLRRQLRKAVMDHVSDSFLETNVPLLVLIEAAKNGNEKEVKEYAQVFREHANKLIEVANLACSISNNEEGVKLVRMSASQLEALCPQVINAALALAAKPQSKLAQENMDLFKEQWEKQVRVLTDAVDDITSIDDFLAVSENHILEDVNKCVIALQEKDVDGLDRTAGAIRGRAARVIHVVTSEMDNYEPGVYTEKVLEATKLLSNTVMPRFTEQVEAAVEALSSDPAQPMDENEFIDASRLVYDGIRDIRKAVLMIRTPEELDDSDFETEDFDVRSRTSVQTEDDQLIAGQSARAIMAQLPQEQKAKIAEQVASFQEEKSKLDAEVSKWDDSGNDIIVLAKQMCMIMMEMTDFTRGKGPLKNTSDVISAAKKIAEAGSRMDKLGRTIADHCPDSACKQDLLAYLQRIALYCHQLNICSKVKAEVQNLGGELVVSGVDSAMSLIQAAKNLMNAVVQTVKASYVASTKYQKSQGMASLNLPAVSWKMKAPEKKPLVKREKQDETQTKIKRASQKKHVNPVQALSEFKAMDSI

PTMs - P35221 基板として

Site PTM Type Enzyme
T2 Phosphorylation
K12 Ubiquitination
K16 Ubiquitination
T38 Phosphorylation
T42 Phosphorylation
S44 Phosphorylation
K45 Ubiquitination
K50 Ubiquitination
K57 Ubiquitination
K75 Ubiquitination
K81 Ubiquitination
S83 Phosphorylation
K87 Ubiquitination
S118 Phosphorylation
Y148 Phosphorylation
K163 Ubiquitination
R165 Methylation
Y177 Phosphorylation
K178 Ubiquitination
K181 Ubiquitination
K186 Acetylation
K186 Ubiquitination
K193 Acetylation
K193 Ubiquitination
K199 Ubiquitination
K216 Ubiquitination
Y222 Phosphorylation
T223 Phosphorylation
Y237 Phosphorylation
K238 Ubiquitination
Y245 Phosphorylation
K246 Ubiquitination
S264 Phosphorylation
S268 Phosphorylation
Y280 Phosphorylation
S295 Phosphorylation
S297 Phosphorylation
S304 Phosphorylation
S311 Phosphorylation
S323 Phosphorylation
S361 Phosphorylation
S366 Phosphorylation
K370 Ubiquitination
T372 Phosphorylation
K384 Ubiquitination
S393 Phosphorylation
K414 Ubiquitination
K417 Ubiquitination
Y419 Phosphorylation
K429 Ubiquitination
S439 Phosphorylation
K448 Ubiquitination
S453 Phosphorylation
S455 Phosphorylation
S477 Phosphorylation
K478 Ubiquitination
K493 Ubiquitination
T506 Phosphorylation
S507 Phosphorylation
K533 Ubiquitination
T541 Phosphorylation
Y563 Phosphorylation
K577 Ubiquitination
Y619 Phosphorylation
T634 Phosphorylation
S641 Phosphorylation P68400 (CSNK2A1)
T645 Phosphorylation
S652 Phosphorylation
T654 Phosphorylation
S655 Phosphorylation
T658 Phosphorylation
S668 Phosphorylation
K681 Ubiquitination
K683 Ubiquitination
S690 Phosphorylation
K695 Ubiquitination
S696 Phosphorylation
K737 Ubiquitination
S744 Phosphorylation
K747 Acetylation
K747 Ubiquitination
S754 Phosphorylation
K758 Ubiquitination
C767 S-Nitrosylation
S770 Phosphorylation
C772 S-Nitrosylation
K773 Ubiquitination
Y779 Phosphorylation
K797 Ubiquitination
Y837 Phosphorylation
K842 Acetylation
K842 Ubiquitination
S846 Phosphorylation
S851 Phosphorylation
S858 Phosphorylation
S886 Phosphorylation
S898 Phosphorylation
K901 Methylation
K901 Ubiquitination
S905 Phosphorylation

研究背景

機能:

Associates with the cytoplasmic domain of a variety of cadherins. The association of catenins to cadherins produces a complex which is linked to the actin filament network, and which seems to be of primary importance for cadherins cell-adhesion properties. Can associate with both E- and N-cadherins. Originally believed to be a stable component of E-cadherin/catenin adhesion complexes and to mediate the linkage of cadherins to the actin cytoskeleton at adherens junctions. In contrast, cortical actin was found to be much more dynamic than E-cadherin/catenin complexes and CTNNA1 was shown not to bind to F-actin when assembled in the complex suggesting a different linkage between actin and adherens junctions components. The homodimeric form may regulate actin filament assembly and inhibit actin branching by competing with the Arp2/3 complex for binding to actin filaments. May play a crucial role in cell differentiation.

PTMs:

Sumoylated.

Phosphorylation seems to contribute to the strength of cell-cell adhesion rather than to the basic capacity for cell-cell adhesion.

細胞の位置付け:

Cytoplasm>Cytoskeleton. Cell junction>Adherens junction. Cell membrane>Peripheral membrane protein>Cytoplasmic side. Cell junction.
Note: Found at cell-cell boundaries and probably at cell-matrix boundaries.

Cell membrane>Peripheral membrane protein>Cytoplasmic side.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
組織特異性:

Expressed ubiquitously in normal tissues.

サブユニット構造:

Monomer and homodimer; the monomer preferentially binds to CTNNB1 and the homodimer to actin. Binds AFDN and F-actin. Possible component of an E-cadherin/ catenin adhesion complex together with E-cadherin/CDH1 and beta-catenin/CTNNB1 or gamma-catenin/JUP; the complex is located to adherens junctions. The stable association of CTNNA1 is controversial as CTNNA1 was shown not to bind to F-actin when assembled in the complex. Alternatively, the CTNNA1-containing complex may be linked to F-actin by other proteins such as LIMA1. Interacts with ARHGAP21 and with AJUBA. Interacts with LIMA1 (By similarity). Interacts with vinculin/VCL. Component of an cadherin:catenin adhesion complex composed of at least of CDH26, beta-catenin/CTNNB1, alpha-catenin/CTNNA1 and p120 catenin/CTNND1.

タンパク質ファミリー:

Belongs to the vinculin/alpha-catenin family.

研究領域

· Cellular Processes > Cellular community - eukaryotes > Adherens junction.   (View pathway)

· Environmental Information Processing > Signal transduction > Hippo signaling pathway.   (View pathway)

· Human Diseases > Infectious diseases: Bacterial > Bacterial invasion of epithelial cells.

· Human Diseases > Cancers: Overview > Pathways in cancer.   (View pathway)

· Human Diseases > Cancers: Specific types > Endometrial cancer.   (View pathway)

· Human Diseases > Cancers: Specific types > Gastric cancer.   (View pathway)

· Human Diseases > Cardiovascular diseases > Arrhythmogenic right ventricular cardiomyopathy (ARVC).

· Organismal Systems > Immune system > Leukocyte transendothelial migration.   (View pathway)

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.